Hikari Okada
Kanazawa, 9208641, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Ligand-dependent reprogramming of HNF4A expression and function suppresses multistep hepatocarcinogenesis.
Journal: Molecular therapy. Oncology
Published: February 03, 2026
Systematic evaluation of long- and short-read RNA-seq for human peripheral blood.
Journal: NAR molecular medicine
Published: October 23, 2025
Mint3 as a Molecular Target Activated in the Early Stage of Hepatocarcinogenesis.
Journal: International journal of molecular sciences
Published: January 09, 2025
Vascular Endothelial Growth Factor Receptor 2-Targeted Therapy Suppresses the Progression of Alpha-Fetoprotein-Positive Hepatocellular Carcinoma After Combination Therapy With Anti-Programmed Death-Ligand 1 and Anti-Vascular Endothelial Growth Factor-A Antibodies.
Journal: Gastro hep advances
Published: December 28, 2024
Apparent reduction in heart rate during oviposition revealed by non-invasive heart rate monitoring of gravid loggerhead turtles.
Journal: Frontiers in physiology
Published: December 05, 2024
Transcription factor JUNB is required for transformation of EpCAM-positive hepatocellular carcinoma (HCC) cells into CD90-positive HCC cells in vitro.
Journal: Cell death & disease
Published: September 22, 2024
Abnormalities of intracellular organelles in metabolic dysfunction-associated steatotic disease.
Journal: Journal of gastroenterology
Published: September 13, 2024
Hepatocyte transformation is induced by laminin γ2 monomer.
Journal: Cancer science
Published: February 26, 2024
Lipid nanoparticle-encapsulated DOCK11-siRNA efficiently reduces hepatitis B virus cccDNA level in infected mice.
Journal: Molecular therapy. Methods & clinical development
Published: December 25, 2023
Potential utility of l-carnitine for preventing liver tumors derived from metabolic dysfunction-associated steatohepatitis.
Journal: Hepatology communications
Published: November 09, 2023
Beta-Hydroxyisovaleryl-Shikonin Eradicates Epithelial Cell Adhesion Molecule-Positive Liver Cancer Stem Cells by Suppressing dUTP Pyrophosphatase Expression.
Journal: International journal of molecular sciences
Published: October 16, 2023
Last Updated: 09/26/2026